Medovex Corp Stock Price To Book
Medovex Corp fundamentals help investors to digest information that contributes to Medovex Corp's financial success or failures. It also enables traders to predict the movement of Medovex OTC Stock. The fundamental analysis module provides a way to measure Medovex Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medovex Corp otc stock.
Medovex |
Medovex Corp OTC Stock Price To Book Analysis
Medovex Corp's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Medovex Corp Price To Book | 34.90 X |
Most of Medovex Corp's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medovex Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Medovex Corp has a Price To Book of 34.9 times. This is 35.9% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The price to book for all United States stocks is notably lower than that of the firm.
Medovex Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medovex Corp's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medovex Corp could also be used in its relative valuation, which is a method of valuing Medovex Corp by comparing valuation metrics of similar companies.Medovex Corp is currently under evaluation in price to book category among its peers.
Medovex Fundamentals
Return On Equity | -4.6 | |||
Return On Asset | -3.48 | |||
Operating Margin | (3.51) % | |||
Current Valuation | 8.88 M | |||
Shares Outstanding | 477.61 K | |||
Shares Owned By Insiders | 25.51 % | |||
Number Of Shares Shorted | 294 | |||
Price To Earning | (1.53) X | |||
Price To Book | 34.90 X | |||
Price To Sales | 3.68 X | |||
Revenue | 1.61 M | |||
Gross Profit | 906.81 K | |||
EBITDA | (4.61 M) | |||
Net Income | (4.8 M) | |||
Cash And Equivalents | 45.88 K | |||
Cash Per Share | 0.16 X | |||
Total Debt | 3.88 M | |||
Debt To Equity | 2.61 % | |||
Current Ratio | 0.04 X | |||
Book Value Per Share | (17.98) X | |||
Cash Flow From Operations | (4.81 M) | |||
Short Ratio | 3.47 X | |||
Earnings Per Share | (0.05) X | |||
Target Price | 1.75 | |||
Beta | 0.73 | |||
Market Capitalization | 1.06 M | |||
Total Asset | 321.4 K | |||
Retained Earnings | (38.35 M) | |||
Working Capital | 3.33 M | |||
Current Asset | 4.18 M | |||
Current Liabilities | 851.22 K | |||
Net Asset | 321.4 K |
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |